{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:50:36Z","timestamp":1791402636893,"version":"4.3.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease leading to permanent damage to the central and peripheral motor neurons. Currently, there is no effective treatment for ALS, and therapy focuses solely on slowing the progression of the disease. Recent studies show that gut microbiota plays an important role in the development of neurodegenerative diseases. Altered gut microbiota has also been found in ALS. These changes have prompted the search for alternative forms of ALS treatment, focusing on changing the microbial composition of the gut. It has been noted that diet, probiotics, prebiotics and vitamins can all influence the course of ALS. Another interesting issue is fecal microbiota transplantation, which is already used in the treatment of certain intestinal diseases and could potentially be useful in the treatment of ALS. This review summarizes current knowledge on the impact of gut microbiota on the neurodegenerative process in ALS, with particular emphasis on the role of diet and probiotics. It also discusses potential mechanisms and highlights future research directions in this emerging field.<\/jats:p>","DOI":"10.1007\/s43440-025-00800-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T03:45:29Z","timestamp":1762227929000},"page":"1514-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dietary modulation of the gut microbiome as a supportive strategy in the treatment of amyotrophic lateral sclerosis \u2013 a narrative review"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-8972","authenticated-orcid":false,"given":"Aneta","family":"Kiecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-2382","authenticated-orcid":false,"given":"Marian","family":"Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005.","journal-title":"Front Immunol"},{"issue":"5","key":"800_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771\u20136.","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"800_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1517\/14728214.2011.604312","volume":"16","author":"AA Habib","year":"2011","unstructured":"Habib AA, Mitsumoto H. Emerging drugs for amyotrophic lateral sclerosis. Expert Opin Emerg Drugs. 2011;16(3):537\u201358.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"3\u20134","key":"800_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/21678421.2019.1572191","volume":"20","author":"A Abraham","year":"2019","unstructured":"Abraham A, Nefussy B, Fainmesser Y, Ebrahimi Y, Karni A, Drory VE. Early post-marketing experience with Edaravone in an unselected group of patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3\u20134):260\u20133.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"800_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/sctm.18-0154","volume":"8","author":"L Mazzini","year":"2019","unstructured":"Mazzini L, Gelati M, Profico DC, Sorar\u00f9 G, Ferrari D, Copetti M, et al. Trial study Group. Results from phase i clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. 2019;8(9):887\u201397.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"800_CR6","doi-asserted-by":"publisher","first-page":"dmm038109","DOI":"10.1242\/dmm.038109","volume":"12","author":"T Jiang","year":"2019","unstructured":"Jiang T, Handley E, Brizuela M, Dawkins E, Lewis KEA, Clark RM, et al. Amyotrophic lateral sclerosis mutant TDP-43 May cause synaptic dysfunction through altered dendritic spine function. Dis Model Mech. 2019;12(5):dmm038109.","journal-title":"Dis Model Mech"},{"issue":"1","key":"800_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12916-024-03781-6","volume":"22","author":"R Feng","year":"2024","unstructured":"Feng R, Zhu Q, Wang A, Wang H, Wang J, Chen P, et al. Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. BMC Med. 2024;22(1):566. https:\/\/doi.org\/10.1186\/s12916-024-03781-6. PMID: 39617896; PMCID: PMC11610222.","journal-title":"BMC Med"},{"issue":"1","key":"800_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/ijms24010587","volume":"24","author":"G Anderson","year":"2022","unstructured":"Anderson G. Amyotrophic lateral sclerosis pathoetiology and pathophysiology: roles of astrocytes, gut microbiome, and muscle interactions via the mitochondrial melatonergic pathway, with disruption by glyphosate-based herbicides. Int J Mol Sci. 2022;24(1):587.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"800_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/phar.1640","volume":"35","author":"SA Flowers","year":"2015","unstructured":"Flowers SA, Ellingrod VL. The Microbiome in mental health: potential contribution of gut microbiota in disease and pharmacotherapy management. Pharmacotherapy. 2015;35(10):910\u20136.","journal-title":"Pharmacotherapy"},{"key":"800_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fcimb.2020.00104","volume":"10","author":"S Askarova","year":"2020","unstructured":"Askarova S, Umbayev B, Masoud AR, Kaiyrlykyzy A, Safarova Y, Tsoy A, et al. The links between the gut microbiome, aging, modern lifestyle and alzheimer\u2019s disease. Front Cell Infect Microbiol. 2020;10:104.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"800_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.clinthera.2015.04.002","volume":"37","author":"AI Petra","year":"2015","unstructured":"Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther. 2015;37(5):984\u201395.","journal-title":"Clin Ther"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"1130689","DOI":"10.3389\/fendo.2023.1130689","volume":"14","author":"JA Rusch","year":"2023","unstructured":"Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne). 2023;14:1130689.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"800_CR13","first-page":"1085","volume":"13","author":"B Buey","year":"2023","unstructured":"Buey B, Forc\u00e9n A, Grasa L, Layunta E, Mesonero JE, Latorre E. Gut microbiota-derived short-chain fatty acids: novel regulators of intestinal serotonin transporter. Life (Basel). 2023;13(5):1085.","journal-title":"Life (Basel)"},{"issue":"3","key":"800_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","volume":"4","author":"P Strandwitz","year":"2019","unstructured":"Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396\u2013403.","journal-title":"Nat Microbiol"},{"issue":"9","key":"800_CR15","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.celrep.2016.04.074","volume":"15","author":"L M\u00f6hle","year":"2016","unstructured":"M\u00f6hle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, Alutis M, et al. Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep. 2016;15(9):1945\u201356.","journal-title":"Cell Rep"},{"issue":"8","key":"800_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"e47117","DOI":"10.7554\/eLife.47117","volume":"8","author":"DG Brown","year":"2019","unstructured":"Brown DG, Soto R, Yandamuri S, Stone C, Dickey L, Gomes-Neto JC, et al. The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling. Elife. 2019;8:e47117.","journal-title":"Elife"},{"issue":"10","key":"800_CR18","first-page":"e47861","volume":"15","author":"A Jain","year":"2023","unstructured":"Jain A, Madkan S, Patil P. The role of gut microbiota in neurodegenerative diseases: current insights and therapeutic implications. Cureus. 2023;15(10):e47861.","journal-title":"Cureus"},{"issue":"2","key":"800_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","volume":"595","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2017;595(2):489\u2013503.","journal-title":"J Physiol"},{"issue":"10","key":"800_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","volume":"74","author":"F Pistollato","year":"2016","unstructured":"Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, Battino M. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of alzheimer disease. Nutr Rev. 2016;74(10):624\u201334.","journal-title":"Nutr Rev"},{"issue":"12","key":"800_CR21","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","volume":"57","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M, Liu K, Zhang HL. Gut microbiota and dysbiosis in alzheimer\u2019s disease: implications for pathogenesis and treatment. Mol Neurobiol. 2020;57(12):5026\u201343.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"800_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00284-022-03150-7","volume":"80","author":"B Yousefi","year":"2022","unstructured":"Yousefi B, Babaeizad A, Banihashemian SZ, Feyzabadi ZK, Dadashpour M, Pahlevan D, et al. Gastrointestinal tract, microbiota and multiple sclerosis (ms) and the link between gut microbiota and Cns. Curr Microbiol. 2022;80(1):38.","journal-title":"Curr Microbiol"},{"issue":"1","key":"800_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13365-015-0357-8","volume":"22","author":"SM Dobbs","year":"2016","unstructured":"Dobbs SM, Dobbs RJ, Weller C, Charlett A, Augustin A, Taylor D, et al. Peripheral aetiopathogenic drivers and mediators of parkinson\u2019s disease and co-morbidities: role of Gastrointestinal microbiota. J Neurovirol. 2016;22(1):22\u201332.","journal-title":"J Neurovirol"},{"issue":"12","key":"800_CR24","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.4103\/NRR.NRR-D-24-00994","volume":"20","author":"SJ Park","year":"2025","unstructured":"Park SJ, Kim KW, Lee EJ. Gut-brain axis and environmental factors in parkinson\u2019s disease: bidirectional link between disease onset and progression. Neural Regen Res. 2025;20(12):3416\u201329.","journal-title":"Neural Regen Res"},{"key":"800_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60\u20138.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"800_CR26","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.xcrm.2021.100398","volume":"2","author":"A Ueda","year":"2021","unstructured":"Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, Kariya T, et al. Identification of Faecalibacterium Prausnitzii strains for gut microbiome-based intervention in Alzheimer\u2019s-type dementia. Cell Rep Med. 2021;2(9):100398.","journal-title":"Cell Rep Med"},{"issue":"6","key":"800_CR27","doi-asserted-by":"publisher","first-page":"e00469","DOI":"10.1016\/j.neurot.2024.e00469","volume":"21","author":"M Kaul","year":"2024","unstructured":"Kaul M, Mukherjee D, Weiner HL, Cox LM. Gut microbiota immune cross-talk in amyotrophic lateral sclerosis. Neurotherapeutics. 2024;21(6):e00469.","journal-title":"Neurotherapeutics"},{"key":"800_CR28","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3389\/fmicb.2016.01479","volume":"7","author":"X Fang","year":"2016","unstructured":"Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, et al. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7:1479.","journal-title":"Front Microbiol"},{"issue":"1","key":"800_CR29","doi-asserted-by":"publisher","first-page":"12998","DOI":"10.1038\/s41598-020-69845-8","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Shen J, Chen K, Zhou J, Liao Q, Lu K, et al. The alteration of gut Microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep. 2020;10(1):12998.","journal-title":"Sci Rep"},{"issue":"15","key":"800_CR30","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/CM9.0000000000000351","volume":"132","author":"CD Zhai","year":"2019","unstructured":"Zhai CD, Zheng JJ, An BC, Huang HF, Tan ZC. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses. Chin Med J (Engl). 2019;132(15):1815\u201322.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"800_CR31","doi-asserted-by":"publisher","first-page":"2353396","DOI":"10.1080\/19490976.2024.2353396","volume":"16","author":"J Yan","year":"2024","unstructured":"Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X, et al. Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Gut Microbes. 2024;16(1):2353396.","journal-title":"Gut Microbes"},{"issue":"1","key":"800_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13075-023-03118-3","volume":"25","author":"J Moon","year":"2023","unstructured":"Moon J, Lee AR, Kim H, Jhun J, Lee SY, Choi JW, et al. Faecalibacterium Prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthritis Res Ther. 2023;25(1):130.","journal-title":"Arthritis Res Ther"},{"issue":"3\u20134","key":"800_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M, Dedi B, et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3\u20134):186\u201394.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1\u20132","key":"800_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21678421.2021.1904994","volume":"23","author":"VS Hertzberg","year":"2022","unstructured":"Hertzberg VS, Singh H, Fournier CN, Moustafa A, Polak M, Kuelbs CA, et al. Gut Microbiome differences between amyotrophic lateral sclerosis patients and spouse controls. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23(1\u20132):91\u20139.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"800_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.55730\/1300-0144.5825","volume":"54","author":"Z \u00d6zaydin Aksun","year":"2024","unstructured":"\u00d6zaydin Aksun Z, Erdo\u011fan S, Kalkanci A, \u015eahin EA, \u00c7uhadar T, et al. Is gut microbiota of patients with ALS different from that of healthy individuals? Turk J Med Sci. 2024;54(3):579\u201387.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"800_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12883-022-02586-5","volume":"22","author":"HS Kim","year":"2022","unstructured":"Kim HS, Son J, Lee D, Tsai J, Wang D, Chocron ES, et al. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol. 2022;22(1):62.","journal-title":"BMC Neurol"},{"issue":"2","key":"800_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awad306","volume":"147","author":"K Guo","year":"2024","unstructured":"Guo K, Figueroa-Romero C, Noureldein MH, Murdock BJ, Savelieff MG, Hur J, et al. Gut Microbiome correlates with plasma lipids in amyotrophic lateral sclerosis. Brain. 2024;147(2):665\u201379.","journal-title":"Brain"},{"issue":"2","key":"800_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","volume":"39","author":"YG Zhang","year":"2017","unstructured":"Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39(2):322\u201336.","journal-title":"Clin Ther"},{"issue":"7","key":"800_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/biomedicines9070753","volume":"9","author":"E Niccolai","year":"2021","unstructured":"Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, et al. The gut Microbiota-Immunity axis in ALS: A role in Deciphering disease. Heterogeneity? Biomedicines. 2021;9(7):753.","journal-title":"Heterogeneity? Biomedicines"},{"issue":"7770","key":"800_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U. Potential roles of gut Microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474\u201380.","journal-title":"Nature"},{"issue":"11","key":"800_CR41","doi-asserted-by":"publisher","first-page":"e0188271","DOI":"10.1371\/journal.pone.0188271","volume":"12","author":"M Tamura","year":"2017","unstructured":"Tamura M, Hoshi C, Kobori M, Takahashi S, Tomita J, Nishimura M, et al. Quercetin metabolism by fecal microbiota from healthy elderly human subjects. PLoS ONE. 2017;12(11):e0188271.","journal-title":"PLoS ONE"},{"issue":"8","key":"800_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jnutbio.2013.05.001","volume":"24","author":"F Cardona","year":"2013","unstructured":"Cardona F, Andr\u00e9s-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortu\u00f1o MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24(8):1415\u201322.","journal-title":"J Nutr Biochem"},{"key":"800_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fimmu.2019.00729","volume":"10","author":"AM Mileo","year":"2019","unstructured":"Mileo AM, Nistic\u00f2 P, Miccadei S. Polyphenols: Immunomodulatory and therapeutic implication in colorectal cancer. Front Immunol. 2019;10:729.","journal-title":"Front Immunol"},{"issue":"4","key":"800_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.18388\/abp.2015_1154","volume":"62","author":"D Gwiazdowska","year":"2015","unstructured":"Gwiazdowska D, Ju\u015b K, Jasnowska-Ma\u0142ecka J, Kluczy\u0144ska K. The impact of polyphenols on bifidobacterium growth. Acta Biochim Pol. 2015;62(4):895\u2013901.","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"800_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/metabo9040078","volume":"9","author":"SL Johnson","year":"2019","unstructured":"Johnson SL, Kirk RD, DaSilva NA, Ma H, Seeram NP, Bertin MJ. Polyphenol microbial metabolites exhibit gut and blood\u207bbrain barrier permeability and protect murine microglia against lps-induced inflammation. Metabolites. 2019;9(4):78.","journal-title":"Metabolites"},{"issue":"8","key":"800_CR46","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1021\/acschemneuro.5b00051","volume":"6","author":"M Gasperotti","year":"2015","unstructured":"Gasperotti M, Passamonti S, Tramer F, Masuero D, Guella G, Mattivi F, et al. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem Neurosci. 2015;6(8):1341\u201352.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"800_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ijms20020351","volume":"20","author":"F Pot\u00ec","year":"2019","unstructured":"Pot\u00ec F, Santi D, Spaggiari G, Zimetti F, Zanotti I. Polyphenol health effects on cardiovascular and neurodegenerative disorders: a review and meta-analysis. Int J Mol Sci. 2019;20(2):351.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"800_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jnutbio.2015.01.002","volume":"26","author":"U Etxeberria","year":"2015","unstructured":"Etxeberria U, Arias N, Boqu\u00e9 N, Macarulla MT, Portillo MP, Mart\u00ednez JA, et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and Quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem. 2015;26(6):651\u201360.","journal-title":"J Nutr Biochem"},{"issue":"13","key":"800_CR49","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1021\/acschemneuro.3c00276","volume":"14","author":"S Sharma","year":"2023","unstructured":"Sharma S, Tomar VR, Deep S, Myricetin. A potent anti-amyloidogenic polyphenol against superoxide dismutase 1 aggregation. ACS Chem Neurosci. 2023;14(13):2461\u201375.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"800_CR50","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/EDE.0b013e3181632c5d","volume":"19","author":"N Morozova","year":"2008","unstructured":"Morozova N, Weisskopf MG, McCullough ML, Munger KL, Calle EE, Thun MJ, et al. Diet and amyotrophic lateral sclerosis. Epidemiology. 2008;19(2):324\u201337.","journal-title":"Epidemiology"},{"issue":"5","key":"800_CR51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/17482960701472249","volume":"8","author":"K Okamoto","year":"2007","unstructured":"Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, et al. Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler. 2007;8(5):300\u20134.","journal-title":"Amyotroph Lateral Scler"},{"issue":"4","key":"800_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","volume":"78","author":"JH Veldink","year":"2007","unstructured":"Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(4):367\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"800_CR53","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/oxfordjournals.aje.a010184","volume":"151","author":"LM Nelson","year":"2000","unstructured":"Nelson LM, Matkin C, Longstreth WT Jr, McGuire V. Population-based case-control study of amyotrophic lateral sclerosis in Western Washington State. II. Diet. Am J Epidemiol. 2000;151(2):164\u201373.","journal-title":"Am J Epidemiol"},{"key":"800_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2202-7-29","volume":"7","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.","journal-title":"BMC Neurosci"},{"issue":"30","key":"800_CR55","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Ren\u00e9 F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a Transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101(30):11159\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"800_CR56","doi-asserted-by":"publisher","first-page":"e49191","DOI":"10.1371\/journal.pone.0049191","volume":"7","author":"W Zhao","year":"2012","unstructured":"Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, et al. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7(11):e49191.","journal-title":"PLoS ONE"},{"issue":"1","key":"800_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mus.22114","volume":"44","author":"S Paganoni","year":"2011","unstructured":"Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(1):20\u20134.","journal-title":"Muscle Nerve"},{"issue":"4","key":"800_CR58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J, K\u00fchnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258(4):613\u20137.","journal-title":"J Neurol"},{"issue":"3","key":"800_CR59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang X, Yu D, Xue L, Li H, Du J. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B. 2020;10(3):475\u201387.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"800_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.11138\/FNeur\/2017.32.1.035","volume":"32","author":"L Libonati","year":"2017","unstructured":"Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, et al. Vitamin D in amyotrophic lateral sclerosis. Funct Neurol. 2017;32(1):35\u201340.","journal-title":"Funct Neurol"},{"key":"800_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jns.2016.05.007","volume":"367","author":"J Yang","year":"2016","unstructured":"Yang J, Park JS, Oh KW, Oh SI, Park HM, Kim SH. Vitamin D levels are not predictors of survival in a clinic population of patients with ALS. J Neurol Sci. 2016;367:83\u20138.","journal-title":"J Neurol Sci"},{"issue":"11","key":"800_CR62","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","volume":"20","author":"C Karam","year":"2013","unstructured":"Karam C, Barrett MJ, Imperato T, MacGowan DJ, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20(11):1550\u20133.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"800_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.20316","volume":"57","author":"A Ascherio","year":"2005","unstructured":"Ascherio A, Weisskopf MG, O\u2019reilly EJ, Jacobs EJ, McCullough ML, Calle EE, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57(1):104\u201310.","journal-title":"Ann Neurol"},{"issue":"1","key":"800_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/146608201300079364","volume":"2","author":"C Desnuelle","year":"2001","unstructured":"Desnuelle C, Dib M, Garrel C, Favier A. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol study group. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(1):9\u201318.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"800_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7555\/JBR.36.20220088","volume":"37","author":"G Lu","year":"2022","unstructured":"Lu G, Wen Q, Cui B, Li Q, Zhang F. Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: the first case report and narrative review. J Biomed Res. 2022;37(1):69\u201376.","journal-title":"J Biomed Res"},{"issue":"4","key":"800_CR66","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","volume":"167","author":"G Sharon","year":"2016","unstructured":"Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut Microbiome. Cell. 2016;167(4):915\u201332.","journal-title":"Cell"},{"issue":"4","key":"800_CR67","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/nu7043011","volume":"7","author":"MT Cantorna","year":"2015","unstructured":"Cantorna MT, Snyder L, Lin YD, Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7(4):3011\u201321.","journal-title":"Nutrients"},{"issue":"11\u201312","key":"800_CR68","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"SC Barber","year":"2006","unstructured":"Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006;1762(11\u201312):1051\u201367.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"800_CR69","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.23820","volume":"73","author":"KC Fitzgerald","year":"2013","unstructured":"Fitzgerald KC, O\u2019Reilly \u00c9J, Fondell E, Falcone GJ, McCullough ML, Park Y, et al. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies. Ann Neurol. 2013;73(2):236\u201345.","journal-title":"Ann Neurol"},{"key":"800_CR70","doi-asserted-by":"publisher","first-page":"103676","DOI":"10.1016\/j.ebiom.2021.103676","volume":"73","author":"W Roth","year":"2021","unstructured":"Roth W, Mohamadzadeh M. Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke. EBioMedicine. 2021;73:103676.","journal-title":"EBioMedicine"},{"issue":"6","key":"800_CR71","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/mus.24969","volume":"53","author":"K Farhad","year":"2016","unstructured":"Farhad K, Traub R, Ruzhansky KM, Brannagan TH 3. Causes of neuropathy in patients referred as idiopathic neuropathy. Muscle Nerve. 2016;53(6):856\u201361.","journal-title":"Muscle Nerve"},{"issue":"1","key":"800_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1615\/CritRevImmunol.2023047231","volume":"43","author":"PC Chen","year":"2023","unstructured":"Chen PC, Kaur K, Ko MW, Huerta-Yepez S, Jain Y, Jewett A. Regulation of cytotoxic immune effector function by aj3 probiotic bacteria in amyotrophic lateral sclerosis (ALS). Crit Rev Immunol. 2023;43(1):13\u201326.","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"800_CR73","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2146\/ajhp090168","volume":"67","author":"NT Williams","year":"2010","unstructured":"Williams NT, Probiotics. Am J Health Syst Pharm. 2010;67(6):449\u201358.","journal-title":"Am J Health Syst Pharm"},{"key":"800_CR74","doi-asserted-by":"publisher","first-page":"929346","DOI":"10.3389\/fmicb.2022.929346","volume":"13","author":"HZ Gou","year":"2022","unstructured":"Gou HZ, Zhang YL, Ren LF, Li ZJ, Zhang L. How do intestinal probiotics restore the intestinal barrier? Front Microbiol. 2022;13:929346.","journal-title":"Front Microbiol"},{"issue":"1","key":"800_CR75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12871-018-0642-1","volume":"18","author":"XD Yang","year":"2018","unstructured":"Yang XD, Wang LK, Wu HY, Jiao L. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis. BMC Anesthesiol. 2018;18(1):177.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"800_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gtc.2016.09.012","volume":"46","author":"SM Vindigni","year":"2017","unstructured":"Vindigni SM, Surawicz CM. Fecal microbiota transplantation. Gastroenterol Clin North Am. 2017;46(1):171\u201385.","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"800_CR77","first-page":"CD013871","volume":"4","author":"NZ Minkoff","year":"2023","unstructured":"Minkoff NZ, Aslam S, Medina M, Tanner-Smith EE, Zackular JP, Acra S, et al. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Cochrane Database Syst Rev. 2023;4(4):CD013871.","journal-title":"Cochrane Database Syst Rev"},{"key":"800_CR78","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2019.01021","volume":"10","author":"J Mandrioli","year":"2019","unstructured":"Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D\u2019Amico R, et al. Study protocol: A randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol. 2019;10:1021.","journal-title":"Front Neurol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00800-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T01:03:40Z","timestamp":1764119020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00800-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00800-y","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}